XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Recs

0
Player Avatar TraderAsh123 (< 20) Submitted: 2/23/2010 11:19:27 PM : Outperform Start Price: $8.22 XNPT Score: -48.41

fill the gap

Featured Broker Partners


Advertisement